Tooth inflammation markers may predict treatment success
NCT ID NCT07261761
First seen Dec 29, 2025 · Last updated Jun 18, 2026 · Updated 26 times
Summary
This study looked at 40 people with tooth inflammation (reversible or irreversible pulpitis) to see if certain immune markers in the blood (IL-8 and IL-10) could predict how well a tooth-saving treatment (vital pulp therapy) works. Participants received the therapy, and researchers checked for pain and healing using scans. The goal was to understand if these markers help diagnose the severity of inflammation and guide treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REVERSIBLE PULPITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Faculty of Dentistry, Mansoura Univeristy
Al Mansurah, Egypt
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.